Miniatura

Fitxers

708538.pdf (9.83 MB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2021-04

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/175116

Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in wild-type mice

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1007/s00401-021-02272-9

Resum

Progressive motor alterations and selective death of striatal medium spiny neurons (MSNs) are key pathological hallmarks of Huntington's disease (HD), a neurodegenerative condition caused by a CAG trinucleotide repeat expansion in the coding region of the huntingtin (HTT) gene. Most research has focused on the pathogenic effects of the resultant protein product(s); however, growing evidence indicates that expanded CAG repeats within mutant HTT mRNA and derived small CAG repeat RNAs (sCAG) participate in HD pathophysiology. The individual contribution of protein versus RNA toxicity to HD pathophysiology remains largely uncharacterized and the role of other classes of small RNAs (sRNA) that are strongly perturbed in HD is uncertain. Here, we demonstrate that sRNA produced in the putamen of HD patients (HD-sRNA-PT) are sufficient to induce HD pathology in vivo. Mice injected with HD-sRNA-PT show motor abnormalities, decreased levels of striatal HD-related proteins, disruption of the indirect pathway, and strong transcriptional abnormalities, paralleling human HD pathology. Importantly, we show that the specific blockage of sCAG mitigates HD-sRNA-PT neurotoxicity only to a limited extent. This observation prompted us to identify other sRNA species enriched in HD putamen with neurotoxic potential. We detected high levels of tRNA fragments (tRFs) in HD putamen, and we validated the neurotoxic potential of an Alanine derived tRF in vitro. These results highlight that HD-sRNA-PT are neurotoxic, and suggest that multiple sRNA species contribute to striatal dysfunction and general transcriptomic changes, favoring therapeutic strategies based on the blockage of sRNA-mediated toxicity.

Matèries

Corea de Huntington, Models animals en la investigació

Matèries (anglès)

Huntington's chorea, Animal models in research

Citació

Col·leccions

Articles publicats en revistes (Biomedicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

CREUS MUNCUNILL, Jordi, GUISADO CORCOLL, Anna, VENTURI, Verónica, PANTANO, Lorena, ESCARAMÍS BABIANO, Geòrgia, GARDIA DE HERREROS, Marta, SOLANGUREN-BEASCOA, Maria, GÁMEZ VALERO, Ana, NAVARRETE, Cristina, MASANA NADAL, Mercè, LLORENS TORRES, Franc, DIAZ-LUCENA, Daniela, PÉREZ NAVARRO, Esther, MARTÍ PUIG, Eulàlia. Huntington's disease brain-derived small RNAs recapitulate associated neuropathology in wild-type mice. _Acta Neuropathologica_. 2021. Vol. 141, núm. 4, pàgs. 565-584. [consulta: 25 de febrer de 2026]. ISSN: 0001-6322. [Disponible a: https://hdl.handle.net/2445/175116]

Exportar metadades

JSON - METS

Compartir registre